Trial Profile
A real life study assessing outcomes in patients with Inflammatory bowel disease initiated Vedolizumab therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Dec 2016
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 26 Dec 2016 New trial record